Loading clinical trials...
Loading clinical trials...
1. To examine the effect of a two-week tDCS intervention of 3 months of continued tDCS intervention versus 3 months of receiving a placebo treatment (dummy). On the costs of performing an action task ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tel-Aviv Sourasky Medical Center
NCT07586553 · Motoric Cognitive Risk Syndrome, Gait, and more
NCT07572942 · Motoric Cognitive Risk Syndrome, Cognitive-Motor Interaction, and more
NCT07223905 · Motoric Cognitive Risk Syndrome
NCT05640141 · Motoric Cognitive Risk Syndrome, Mild Cognitive Impairment, and more
NCT04492241 · Motoric Cognitive Risk Syndrome, Mild Cognitive Impairment, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions